Lochan Shah, MD
@lochanshahmdPassionate about the intersection of med, tech, & policy. Proud alum @hopkinsmedicine & @ucberkeley. Cardiology fellow at @KPncalCVFellows
Similar User
@MMukherjeeMD
@RobHughesMD
@TLeucker
@DoctorMarvelMD
@FZghyer
@AnnaShah_MD
@tinazhangmd
@NeelKoyawala
@yesantharao
@grammargandhi
@NinoIsakadze
@adoma_kwapong
@TySweeney6
SO EXCITED TO HAVE MATCHED TO KAISER-SF!!! I’m going to be a cardiologist!!
SO proud of my fantastic chief, could not think of a more deserving person for this award!! @KPncalCVfellows
A HUGE thank you to my co-authors (Jennifer Ting, Rosendo So-Rosillo, Steven Colicci and Mike Ren), KP NCAL and our patient’s family!!! The most humbling award of my professional career. Thank you to the AHA Laennec Committee and judges/panelists. Great to meet the pericardial…
Another great #AHA with new friends and old! Always inspiring to see you @GarimaVSharmaMD @SethShayMartin @DoctorMarvelMD @DrSpaulding_PhD @NinoIsakadze
Off the charts graphic by the great @RawanAAmir! Read more to learn about PFO
To close or not to close? 🤔 That is the ultimate #PFO question🫀 Get the inside scoop on keys 🔑 to diagnosis & when referral for closure is the right call for your patients🤓 Huge thanks to @RichardAFerraro @AmitGoyalMD @a_h_ghoneem @TDonisan @CardioNerds !🫀 #CardioTwitter
Fantastic, quick teaching case from #NEJM on diffuse subendocardial ischemia ECG findings for trainees and providers to keep in mind across #MedX
Really incredible work in @JACCJournals on one-time lipid levels in young adults Look at HR for later ASCVD and events! So, what do we do about it?
Alright team, getting on the same page Infographic on screening & surgery recs for heritable diseases from 2022 ACC/AHA Aorta guidelines Making these for myself #Cardiology boards, but hope helps in general. Hopefully more of these to come Thoughts always appreciated
Super interesting perspective on the pros and cons of using mortality as the endpoint in critical care trials, and caveats to think about when interpreting these trials. Thanks @TheSurajKannan for sharing!
I've obviously been biased by all the exceptional GDMT trials of the last several years, so this was a helpful post on clinical trial endpoints (and why mortality might always be the most useful): emcrit.org/pulmcrit/morta…
This is awesome!!! Love seeing examples of advocacy works!
#HB1388 is signed!!! Non-competes will be strictly regulated in Maryland! Restrictive covenants are banned for all under $350k, and limited to 1 year and 10 miles from primary practice location for >350k. This is huge for patient continuity of care and for health professional…
More FREE #MedEd! I've looked a long time for this Phenomenal video on echo artifacts. Probably the best review I've found Thanks to @IACaccred and @ASE360 for putting this out youtube.com/watch?v=YOMJIK…
A FANTASTIC summary of #ACC24. Most excited about REDUCE-AMI, ULTIMATE-DAPT, & CRESCENT - Looking forward to seeing how these might change practice. Particularly excited about MAD devices - now we need longer term fup + resources on the best devices to recc to pts.
Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch 1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart…
11 mo f/up is pretty solid, and no sig difference in MACCE with ticag monotherapy after 1 mo post-PCI is INCREDIBLE! Wonder if this will change guidelines - my only Q is if they will do a sub-analysis looking at differences in pts with single vessel dz vs multivessel dz? #ACC24
#ACC24 Ultimate DAPT trial with some incredible results ⬇️ bleeding WITHOUT ⬆️ in cardiovascular events How do the guidelines change to reflect this? Fellows and attendings on consult teams everywhere watching @JACCJournals
So sad I’m missing ACC this year and missed this incredible talk! @GarimaVSharmaMD
Excellent talk today by my amazing mentor @GarimaVSharmaMD on the #Top10 relevant clinical practice updates in #CVD during #pregnancy and the #postpartum period at #ACC24 🫀 Key points 👇
Congratulations @Ellen_A_Boakye and team!!
Cardiovascular Risk Profile Among Reproductive-Aged Women. Worsening suboptimal CVH largely explained by increase In obesity @Ellen_A_Boakye @MichaelJBlaha @khurramn1 @HeartDocSadiya @mchonig ajpmfocus.org/article/S2773-…
This is the scariest thing I’ve read in, maybe ever Incredible work in @NEJM nejm.org/doi/full/10.10…
In our new @JACCJournals article, we created the first CAC age-sex-race percentile calculator (cac-tools.com) for US young adults aged 30-45 from a cohort of 19,725, the largest study of CAC in this population to date. sciencedirect.com/science/articl… Why it matters 👇(1/9)
United States Trends
- 1. Pete 308 B posts
- 2. DeSantis 35,6 B posts
- 3. Jokic 12,6 B posts
- 4. Kerr 7.338 posts
- 5. Mavs 12,6 B posts
- 6. Podz 3.438 posts
- 7. Clemson 25,3 B posts
- 8. Wiggins 2.789 posts
- 9. Nuggets 17,1 B posts
- 10. Brea 2.685 posts
- 11. Jamal Murray 1.533 posts
- 12. Kentucky 19,2 B posts
- 13. Kuminga 2.370 posts
- 14. azealia 4.373 posts
- 15. Marcus Smart 2.703 posts
- 16. XDefiant 18,6 B posts
- 17. NBA Cup 15,5 B posts
- 18. #MFFL 4.183 posts
- 19. Knicks 16 B posts
- 20. #HonkaiStarRail 103 B posts
Who to follow
-
Monica Mukherjee MD, MPH
@MMukherjeeMD -
Robert Hughes, MD PhD
@RobHughesMD -
Thorsten Leucker
@TLeucker -
Francoise Marvel, MD
@DoctorMarvelMD -
Fawzi Zghyer
@FZghyer -
Anna Shah, MD
@AnnaShah_MD -
Tina Zhang
@tinazhangmd -
Neel Koyawala
@NeelKoyawala -
Pooja Yesantharao, MD MS
@yesantharao -
Priyal Gandhi, MD
@grammargandhi -
Nino Isakadze
@NinoIsakadze -
Yaa Adoma Kwapong, MD, MPH
@adoma_kwapong -
Ty Sweeney, MD
@TySweeney6
Something went wrong.
Something went wrong.